查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1830980

空心膠囊市場

Empty Capsules Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

空心膠囊市場預計將大幅成長，從 2024 年的 77.9 億美元增加到 2031 年的 136.8 億美元，預計 2025 年至 2031 年期間的複合年成長率為 8.5%。

分析師觀點：本報告概述了基於空膠囊市場當前趨勢的成長機會及其在預測期內的預期影響。市場成長的主要驅動力包括老年人口的成長、製藥、營養保健品和化妝品產業對空膠囊的需求增加，以及消費者對膠囊而非藥片的日益偏好。老年人群通常患有慢性疾病，是製藥商關注的重點。老年人傾向於選擇膠囊，因為它們更容易吞嚥、溶解更快、且引起的胃腸不適更少。然而，原料成本上漲以及對膠囊生產中使用的動物性成分的文化或宗教擔憂等挑戰可能會阻礙市場成長。此外，原料供應有限、對明膠生產商的嚴格監管以及飲食限制也對市場擴張構成挑戰。

市場概覽：推動空心膠囊市場成長的因素包括膠囊作為首選藥物遞送方式的日益普及，以及膠囊供應商和明膠製造商之間的策略合作夥伴關係。此外，研發活動、臨床試驗、新產品的推出以及膠囊遞送技術的進步預計將顯著影響未來幾年的市場預測。例如，2019年11月，Qualicaps, Inc. 在2019年世界製藥原料藥（CPHI）全球大會上推出了硬膠囊劑型。

策略洞察市場驅動力：蓬勃發展的營養保健品和膳食補充劑行業推動市場擴張一項題為「營養保健品聯繫：一站式揭開完整營養解決方案」的研究報告稱，2021 年全球營養保健品市場價值為 4545.5 億美元，預計 2021 年至 2030 年的複合年成長率為 9.0%。此外，美國國際貿易管理局預測，到 2023 年，印度將佔全球營養保健品市場價值的約 3.5%，印度營養保健品產業預計將從 2020 年的約 40 億美元擴大到 2025 年的 180 億美元。營養保健品和補充劑行業提供維生素、礦物質、草藥萃取物、益生菌和其他生物活性化合物，這些通常需要封裝以方便食用。空心膠囊作為一種高效且適應性強的成分輸送系統，使製造商能夠生產出各種產品。它們使製造商能夠根據特定的成分、劑量和目標群體定製配方。這種適應性在營養保健品和膳食補充劑領域至關重要，因為不同的產品需要不同的劑量和成分組合。因此，填充營養保健品或膳食補充劑的膠囊可以幫助製造商滿足消費者對品質、便利性和功效的需求，從而顯著推動了對空心膠囊的需求。

分段分析：透過檢查以下分段對空膠囊市場進行分析：產品、功能、應用和最終用戶。

就產品而言，空心膠囊市場分為明膠膠囊和非明膠膠囊。明膠膠囊在2022年佔據了更大的市場佔有率，而非明膠膠囊預計在2022年至2030年期間的複合年成長率將達到9.0%。膠囊製造商青睞明膠，因為它能夠促進藥物快速釋放和均勻混合，有助於防止藥物分子氧化。然而，人們對動物產品過敏的擔憂日益加劇，也推動了對非明膠膠囊的需求。此外，越來越多的純素食者和素食者傾向於選擇植物性替代品，預計未來幾年該領域將迎來成長。

空心膠囊市場依功能分類，包括速釋膠囊、緩釋膠囊和緩釋膠囊。速釋膠囊在2022年佔據了最大的市場佔有率，預計在預測期內將實現8.5%的最高複合年成長率。在抗酸藥和抗菌抗生素的生產和包裝領域，對速釋膠囊的需求尤其高。 Nitta Gelatin India在2022年6月發表的一篇文章指出，速釋膠囊療法常用於治療各種常見疾病和病症。

根據應用，空心膠囊市場分為抗生素和抗菌藥物、維生素和膳食補充劑、制酸劑和抗脹氣製劑等。抗生素和抗菌藥物部門在 2022 年佔據最大市場佔有率，而維生素和膳食補充劑部門預計在 2022 年至 2030 年期間以 8.9% 的複合年成長率成長最快。抗生素和抗菌藥物用於預防或治療微生物感染。傳染病發生率的上升、中低收入國家對抗生素的需求增加以及主要製藥公司對研發的投資不斷增加是推動抗生素和抗菌藥物生產和包裝對空心膠囊需求的關鍵因素。維生素和補充劑部門的成長歸因於全球老齡人口的成長、對治療藥物的需求的增加以及營養補充劑對改善健康狀況的日益普及。

依最終用戶分類，空心膠囊市場可分為製藥業、營養保健品產業、化妝品產業和研究實驗室。製藥業在2022年佔據最大市場佔有率，預計2022年至2030年期間的複合年成長率最高，為8.4%。膠囊因其適口性較好、吸收較快而成為最常見的固體劑型。這些空心膠囊滿足了製藥業治療各種慢性和傳染病的嚴格要求。此外，製藥業的進步，包括研發投入的增加、臨床研究活動的開展以及膠囊給藥技術的創新，預計將在預測期內支持該領域的成長。

區域分析：空膠囊市場報告涵蓋北美、歐洲、亞太地區、中東和非洲以及南美和中美。 2022 年北美市場價值 18.3 億美元，預計到 2030 年將達到 34.5 億美元，2022 年至 2030 年的複合年成長率為 8.3%。北美空膠囊市場分為美國、加拿大和墨西哥。該地區的成長歸因於人們對膠囊營養保健品配方的日益偏好，這些配方有助於緩解癌症、肥胖和關節炎等嚴重健康問題。慢性病盛行率的上升，尤其是在美國老年人口中，也促進了市場的成長。根據美國人口參考局發布的《人口公報：美國老化》，預計到2060年，65歲及以上美國人的數量將從2018年的5,200萬增加近一倍，達到9,500萬人。美國和加拿大完善的醫療保健體系吸引全球企業進入這些市場，從而催生了許多全球性企業的強勁發展。這些在該地區營運的國際公司滿足了市場對空心膠囊的旺盛需求。

歐洲佔據空心膠囊市場的第三大佔有率，其成長歸因於疾病盛行率的上升、藥物可及性的提高以及研發活動的增加。英國佔歐洲空心膠囊市場的最大佔有率，而德國預計將在預測期內實現最快的成長。

預計 2022 年至 2030 年期間，亞太地區的全球空膠囊市場複合年成長率將最高。該地區的成長得益於可支配收入的增加和人們對營養補充劑日益成長的興趣。隨著氣候條件的變化和勞動力的擴大，人們對護膚的意識不斷增強，導致使用空的 HPMC 膠囊來封裝精油、維生素和抗氧化劑等有效成分，從而促進了該地區空膠囊行業的發展。根據印度品牌股票基金的數據，印度美容和個人護理市場規模從 2019 年的 99.8 億美元成長到 2021 年的 151 億美元。因此，蓬勃發展的化妝品和製藥業，尤其是韓國、印度、日本和中國，預計將在預測期內推動亞太地區空膠囊市場的成長。

空膠囊市場報告範圍關鍵參與者分析：空膠囊市場報告中介紹的關鍵參與者包括 Erawat Pharma Limited、Sunil Healthcare、ACG Worldwide、Medi-Caps Ltd、Lonza Group (Capsugel)、Capscanada Corporation、Bright Pharma Caps Inc、Farmacapsulas、三菱化學控股公司 (Qualicaps, Inc.) 和 Roxlor LLC。

最新動態：市場參與者正在採取併購等策略。市場近期的一些發展包括：

2023年3月，ACG旗下子公司VANTAGE NUTRITION收購了美國ComboCap公司和南非BioCap公司，以增強其在北美及全球的技術和影響力。 2022年1月，西安樂紐特拉配料有限公司向歐洲拉脫維亞出口了800萬粒HPMC膠囊，這些膠囊不含二氧化鈦（TiO2），以響應歐盟委員會在食品添加劑中使用二氧化鈦的禁令，彰顯了該公司致力於滿足區域需求的承諾。 2022年7月，Akums Drug & Pharmaceuticals Ltd.批准了其位於印度哈里德瓦爾的空硬明膠膠囊生產設施。這家總部位於歐盟的公司因遵守良好生產規範（GMP）而獲得認可。 2022年2月，Lyfe Group旗下公司CapsCanada獲得批准，其基於PLxGuard藥物輸送平台的液體填充阿斯匹靈膠囊可用於將藥物輸送到胃腸道的目標區域。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：空心膠囊市場概況

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：空心膠囊市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：空心膠囊市場 - 全球市場分析

  • 空心膠囊 - 全球市場概覽
  • 空心膠囊－全球市場及2030年預測

第7章：空心膠囊市場-收入分析-依產品，2020-2030

  • 概述
  • 明膠膠囊
  • 非明膠膠囊
  • 其他

第8章：空心膠囊市場-收入分析-依治療應用，2020-2030

  • 概述
  • 抗生素和抗菌藥物
  • 維生素和膳食補充劑
  • 制酸劑和抗脹氣劑
  • 其他

第9章：空心膠囊市場-收入分析-按功能，2020-2030

  • 概述
  • 速釋膠囊
  • 緩釋膠囊
  • 緩釋膠囊

第 10 章：空心膠囊市場 - 收入分析 - 按最終用戶，2020-2030 年

  • 概述
  • 製藥業
  • 營養保健品產業
  • 化妝品產業
  • 研究實驗室

第 11 章：空心膠囊市場 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 13 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 14 章：空心膠囊市場 - 主要公司簡介

  • Caps Canada
  • Sunil Healthcare
  • Farmacapsulas
  • Roxlor LLC
  • Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
  • Lonza Capsules and Health Ingredients
  • Bright Pharma Caps Inc
  • ACG Worldwide
  • Medi-Caps Ltd
  • Erawat Pharma Limited

第 15 章：附錄

簡介目錄
Product Code: TIPRE00003411

The empty capsules market is anticipated to grow significantly, increasing from US$ 7.79 billion in 2024 to US$ 13.68 billion by 2031, with an estimated CAGR of 8.5% during the period from 2025 to 2031.

Analyst Perspective:This report outlines growth opportunities based on current trends in the empty capsules market and their expected effects throughout the forecast period. Key drivers of market growth include the rising elderly population, heightened demand for empty capsules across the pharmaceutical, nutraceutical, and cosmetic sectors, and a growing consumer preference for capsules over tablets. The elderly demographic, often dealing with chronic illnesses, is a primary focus for pharmaceutical manufacturers. Older adults tend to favor capsules because they are easier to swallow, dissolve faster, and cause less gastrointestinal discomfort. However, challenges such as increasing raw material costs and cultural or religious concerns regarding the animal-derived ingredients used in capsule production may impede market growth. Additionally, limited raw material availability, strict regulations for gelatin producers, and dietary restrictions also pose challenges to market expansion.

Market Overview:Factors propelling the growth of the empty capsules market include the rising acceptance of capsules as a preferred drug delivery method and strategic partnerships between capsule suppliers and gelatin manufacturers. Moreover, an increase in research and development activities, clinical trials, new product introductions, and advancements in capsule delivery technologies are expected to significantly influence the market forecast in the upcoming years. For example, in November 2019, Qualicaps, Inc. introduced a hard capsule dosage form at the CPHI WORLDWIDE 2019 conference.

Strategic Insights

Market Driver:Thriving Nutraceutical and Dietary Supplement Industries Fuel Market Expansion

A research study titled "The Nutraceutical Nexus: Unveiling The Complete Nutrient Solution In One Place" reported that the global nutraceuticals market was valued at US$ 454.55 billion in 2021 and is projected to grow at a CAGR of 9.0% from 2021 to 2030. Furthermore, the US International Trade Administration forecasts that India will represent approximately 3.5% of the global nutraceutical market value by 2023, with the Indian nutraceutical sector expected to expand from around US$ 4 billion in 2020 to US$ 18 billion by 2025. The nutraceutical and supplement industries provide vitamins, minerals, herbal extracts, probiotics, and other bioactive compounds, which often require encapsulation for convenient consumption. Empty capsules serve as an effective and adaptable delivery system for these ingredients, allowing manufacturers to create a variety of products. They enable manufacturers to customize formulations according to specific ingredients, dosages, and target demographics. This adaptability is crucial in the nutraceutical and dietary supplement sectors, where different products necessitate varying dosages and ingredient combinations. Consequently, capsules filled with nutraceuticals or dietary supplements help manufacturers fulfill consumer demands for quality, convenience, and efficacy, significantly driving the demand for empty capsules.

Segmental Analysis:The analysis of the empty capsules market has been conducted by examining the following segments: product, functionality, application, and end user.

In terms of product, the empty capsules market is divided into gelatin capsules and non-gelatin capsules. The gelatin capsules segment held a larger market share in 2022, while the non-gelatin capsules segment is projected to experience a higher CAGR of 9.0% from 2022 to 2030. The preference for gelatin among capsule manufacturers is due to its ability to facilitate rapid drug release and uniform drug mixing, which helps prevent the oxidation of drug molecules. However, increasing concerns regarding allergies to animal products have also driven demand for non-gelatin capsules. Additionally, the growing vegan and vegetarian population is leaning towards plant-based alternatives, leading to anticipated growth in this segment in the coming years.

The empty capsules market, categorized by functionality, includes immediate-release capsules, delayed-release capsules, and sustained-release capsules. The immediate-release capsules segment accounted for the largest market share in 2022 and is expected to achieve the highest CAGR of 8.5% during the forecast period. The demand for immediate-release capsules is particularly high in the manufacturing and packaging of antacids and antibacterial antibiotics. An article published by Nitta Gelatin India in June 2022 noted that therapeutics in immediate-release capsules are commonly prescribed for various prevalent diseases and disorders.

Based on application, the empty capsules market is segmented into antibiotics and antibacterial drugs, vitamins and dietary supplements, antacids and antiflatulent preparations, and others. The antibiotics and antibacterial drugs segment held the largest market share in 2022, while the vitamins and dietary supplements segment is expected to grow at the fastest CAGR of 8.9% from 2022 to 2030. Antibiotics and antibacterial drugs are used to prevent or treat microbial infections. The rising incidence of infectious diseases, increased demand for antibiotics in low- and middle-income countries, and growing investments in research and development by major pharmaceutical companies are key factors driving the demand for empty capsules in the manufacturing and packaging of antibiotics and antibacterial drugs. The growth of the vitamins and supplements segment is attributed to the expanding elderly population globally, rising demand for therapeutic drugs, and the increasing popularity of nutritional supplements for improved health outcomes.

By end user, the empty capsules market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. The pharmaceutical industry segment held the largest market share in 2022 and is expected to register the highest CAGR of 8.4% from 2022 to 2030. Capsules are the most common solid dosage forms due to their improved palatability and faster absorption. These empty capsules fulfill the pharmaceutical industry's stringent requirements for treating various chronic and infectious diseases. Furthermore, advancements in the pharmaceutical sector, including increased R&D, clinical research activities, and technological innovations in capsule administration, are expected to support the growth of this segment during the forecast period.

Regional Analysis:The empty capsules market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North American market was valued at US$ 1.83 billion in 2022 and is projected to reach US$ 3.45 billion by 2030, with an expected CAGR of 8.3% from 2022 to 2030. The North American empty capsules market is segmented into the US, Canada, and Mexico. The growth in this region is attributed to the increasing preference for capsule-based nutraceutical formulations that help mitigate serious health issues such as cancer, obesity, and arthritis. The rising prevalence of chronic diseases, particularly among the elderly population in the US, also contributes to market growth. According to the Population Reference Bureau's Population Bulletin: Aging in the US, the number of Americans aged 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060. The well-established healthcare systems in the US and Canada encourage global market companies to enter these markets, resulting in a strong presence of numerous global players. The high demand for empty capsules is met by these international companies operating in the region.

Europe holds the third largest share of the empty capsules market, with growth attributed to the rising prevalence of diseases, improved drug accessibility, and increased research and development activities. The UK accounted for the largest share of the empty capsules market in Europe, while Germany is expected to experience the fastest growth during the forecast period.

The Asia Pacific region is projected to achieve the highest CAGR in the global empty capsules market from 2022 to 2030. The growth in this region is driven by rising disposable incomes and a growing interest in nutritional supplements. With changing climate conditions and an expanding workforce, there is a heightened awareness of skincare, leading to the use of empty HPMC capsules for encapsulating effective ingredients such as essential oils, vitamins, and antioxidants, thereby fostering the growth of the empty capsule industry in the region. According to the Indian Brand Equity Fund, the Indian beauty and personal care market grew to US$ 15.1 billion in 2021, up from US$ 9.98 billion in 2019. Consequently, the booming cosmetics and pharmaceutical industries, particularly in South Korea, India, Japan, and China, are expected to drive the growth of the empty capsules market in Asia Pacific during the forecast period.

Empty Capsules Market Report Scope

Key Player Analysis:Key players profiled in the empty capsules market report include Erawat Pharma Limited, Sunil Healthcare, ACG Worldwide, Medi-Caps Ltd, Lonza Group (Capsugel), Capscanada Corporation, Bright Pharma Caps Inc, Farmacapsulas, Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), and Roxlor LLC.

Recent Developments:Market participants are engaging in strategies such as mergers and acquisitions. Some recent developments in the market include:

In March 2023, VANTAGE NUTRITION, a subsidiary of ACG, acquired ComboCap, Inc. (US) and BioCap (South Africa) to enhance its technology and presence in North America and globally.In January 2022, Xi'an Le-Nutra Ingredients Inc. shipped 8.0 million HPMC capsules to Latvia, Europe, which were free from titanium dioxide (TiO2) following the European Commission's ban on TiO2 in food additives, demonstrating the company's commitment to meeting regional demand.In July 2022, Akums Drug & Pharmaceuticals Ltd. approved its empty hard gelatin capsule manufacturing facilities in Haridwar, India. This EU-based company is recognized for adhering to Good Manufacturing Practices (GMP).

In February 2022, CapsCanada, a Lyfe Group company, received approval for a liquid-filled aspirin capsule based on the PLxGuard drug delivery platform, designed to deliver medications to targeted areas of the gastrointestinal tract.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Empty Capsules Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Empty Capsules Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Empty Capsules Market - Global Market Analysis

  • 6.1 Empty Capsules - Global Market Overview
  • 6.2 Empty Capsules - Global Market and Forecast to 2030

7. Empty Capsules Market - Revenue Analysis (USD Million) - By Product, 2020-2030

  • 7.1 Overview
  • 7.2 Gelatin Capsules
    • 7.2.1 Porcine
    • 7.2.2 Bovine
    • 7.2.3 Bone
    • 7.2.4 Others
  • 7.3 Non-Gelatin Capsules
  • 7.4 Others

8. Empty Capsules Market - Revenue Analysis (USD Million) - By Therapeutic Application, 2020-2030

  • 8.1 Overview
  • 8.2 Antibiotic and Antibacterial Drugs
  • 8.3 Vitamins and Dietary Supplements
  • 8.4 Antacid and Antiflatulent Preparations
  • 8.5 Others

9. Empty Capsules Market - Revenue Analysis (USD Million) - By Functionality, 2020-2030

  • 9.1 Overview
  • 9.2 Immediate-Release Capsule
  • 9.3 Delayed-Release Capsules
  • 9.4 Sustained-Release Capsules

10. Empty Capsules Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 10.1 Overview
  • 10.2 Pharmaceutical Industry
  • 10.3 Nutraceutical Industry
  • 10.4 Cosmetics Industry
  • 10.5 Research Laboratories

11. Empty Capsules Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Empty Capsules Market Overview
    • 11.1.2 North America Empty Capsules Market Revenue and Forecasts to 2030
    • 11.1.3 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Product
    • 11.1.4 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Therapeutic Application
    • 11.1.5 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Functionality
    • 11.1.6 North America Empty Capsules Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Empty Capsules Market
        • 11.1.7.1.1 United States Empty Capsules Market, by Product
        • 11.1.7.1.2 United States Empty Capsules Market, by Therapeutic Application
        • 11.1.7.1.3 United States Empty Capsules Market, by Functionality
        • 11.1.7.1.4 United States Empty Capsules Market, by End User
      • 11.1.7.2 Canada Empty Capsules Market
        • 11.1.7.2.1 Canada Empty Capsules Market, by Product
        • 11.1.7.2.2 Canada Empty Capsules Market, by Therapeutic Application
        • 11.1.7.2.3 Canada Empty Capsules Market, by Functionality
        • 11.1.7.2.4 Canada Empty Capsules Market, by End User
      • 11.1.7.3 Mexico Empty Capsules Market
        • 11.1.7.3.1 Mexico Empty Capsules Market, by Product
        • 11.1.7.3.2 Mexico Empty Capsules Market, by Therapeutic Application
        • 11.1.7.3.3 Mexico Empty Capsules Market, by Functionality
        • 11.1.7.3.4 Mexico Empty Capsules Market, by End User
  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Empty Capsules Market - Key Company Profiles

  • 14.1 Caps Canada
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sunil Healthcare
  • 14.3 Farmacapsulas
  • 14.4 Roxlor LLC
  • 14.5 Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
  • 14.6 Lonza Capsules and Health Ingredients
  • 14.7 Bright Pharma Caps Inc
  • 14.8 ACG Worldwide
  • 14.9 Medi-Caps Ltd
  • 14.10 Erawat Pharma Limited

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud